Audience: Individuals with Tourette Syndrome or another Tic Disorder, families and caregivers, researchers, clinicians, and other community members
About the Science in Action Showcase: The Science in Action Showcase is a webinar series designed to provide up to date information on important scientific, clinical, and technological advancements shaping Tourette Syndrome research in 2026. Led by leading experts across neuroscience, behavioral therapy, neuromodulation, and pharmacology, this series turns complex science into digestible, engaging conversations. Participants will learn what’s new, what’s promising, and what’s on the horizon for improving care, treatment, and quality of life for those who experience tics. Browse the other webinars in this series.
Inside the TS Brain: What 2026 Science Reveals
Join Dr. Max Tischfield for an in-depth exploration of the current scientific landscape of TS, including the latest research on the brain, genetics, and neurodevelopmental pathways that contribute to TS. This session will cover major discoveries that have shaped our understanding of the disorder, including insights into genetic risk factors, neural circuits involved in tic expression, and the interplay between neurodevelopmental processes and environmental influences. Attendees will learn about emerging research topics, innovative study methods, and how these advances are informing the development of future treatment strategies. By providing a comprehensive, scientific foundation, this session sets the stage for a deeper dive into clinical approaches, behavioral interventions, and pharmacologic treatments later in the series.
Key Takeaways:
- Gain a clear understanding of the genetic, neurological, and developmental factors behind TS
- Learn about major scientific discoveries and emerging topics shaping TS research
- Understand how these insights inform future treatment approaches and therapeutic innovations
Dr. Max Tischfield
Dr. Tischfield is an assistant professor in the Department of Cell Biology and Neuroscience at Rutgers University. He received his Ph.D. from the Program in Neuroscience at Harvard Medical School and completed postdoctoral studies at Johns Hopkins Medical School and Boston Children’s Hospital. His research leverages human gene discoveries to genetically engineer mouse models for Tourette syndrome that express the identical human mutations found in high-confidence TS genes. Through partnerships with TAA and also the New Jersey Center for Tourette Syndrome, Dr. Tischfield is a proud advocate for Tourette awareness and research throughout the local and national communities.
Other Science in Action Showcase Webinars:
